HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...
Pharmaceutical Technology on MSN
Regeneron and Tessera join forces to forge in vivo AATD gene therapy
If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...
KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell ...
The Brighterside of News on MSN
Researchers discovered how the brain decides what to remember
A song from childhood can hit you out of nowhere. A smell can carry you back decades. Then again, yesterday’s errands fade ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
Georgia students broke into the world spotlight after showcasing early Lyme detection advances that could save patients years of suffering.
Pharmaceutical Technology on MSN
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...
Researchers release a comprehensive viral genome database covering diverse ecosystems to advance understanding of viral ...
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
Researchers have developed VIRE, a database that integrates approximately 1.7 million viral genomes derived from more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results